Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23567214 | 0.93 | HTT (0.39) | TSHRSMN1; SMN2MEN1THRBHTT | |
| SCHEMBL23567289 | 0.91 | HTT (0.42) | TSHRSMN1; SMN2MEN1THRBHTT | |
| SCHEMBL23567257 | 0.91 | HTT (0.42) | TSHRSMN1; SMN2MEN1THRBHTT | |
| SCHEMBL23567223 | 0.91 | HTT (0.42) | TSHRSMN1; SMN2MEN1THRBHTT | |
| SCHEMBL23567269 | 0.91 | HTT (0.42) | TSHRSMN1; SMN2MEN1THRBHTT | |
| SCHEMBL23567246 | 0.91 | HTT (0.42) | TSHRSMN1; SMN2MEN1THRBHTT | |
| SCHEMBL23567300 | 0.91 | TSHR (0.39) | TSHRCYP3A4SMN1; SMN2HPGDADRB2 | |
| SCHEMBL16645786 | 0.91 | — | — | |
| SCHEMBL23567249 | 0.89 | TSHR (0.38) | TSHRCYP3A4SMN1; SMN2HPGDADRB2 | |
| SCHEMBL23567226 | 0.87 | MAPT (0.38) | TSHRCYP3A4SMN1; SMN2HPGDADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12060323-B2 | 6-hydroxy-3-hexenyl alkoxymethyl ether compound and a process for preparing a 3,13-octadecadien-1-ol compound from the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-08-13 | — | — | US | disclosed |
| CN-113024359-B | Process for preparing alkoxymethyl alkynyl ether compounds having terminal triple bonds | 信越化学工业株式会社 | 2024-06-11 | — | — | CN | disclosed |
| EP-3842406-B1 | PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND | SHINETSU CHEMICAL CO (JP) | 2023-10-11 | — | — | EP | disclosed |
| US-20230312454-A1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-05 | — | — | US | disclosed |
| US-20230312454-A1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-05 | — | — | US | disclosed |
| EP-3978465-B1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | SHINETSU CHEMICAL CO (JP) | 2023-06-14 | — | — | EP | disclosed |
| US-11661394-B2 | 6-hydroxy-3-hexenyl alkoxymethyl ether compound and a process for preparing a 3,13-octadecadien-1-ol compound from the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-30 | — | — | US | disclosed |
| US-11384041-B2 | Process for preparing an alkoxymethyl alkynyl ether compound having a terminal triple bond | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-07-12 | — | — | US | disclosed |
| CN-114380669-A | 6-hydroxy-3-hexenylalkoxymethyl ether compounds and process for preparing 3, 13-octadecadien-1-ol therefrom | 信越化学工业株式会社 | 2022-04-22 | — | — | CN | disclosed |
| US-20220106252-A1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-04-07 | — | — | US | disclosed |
| US-20210198172-A1 | PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-07-01 | — | — | US | disclosed |
| EP-3842406-A1 | PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-06-30 | — | — | EP | disclosed |
| CN-113024359-A | Method for producing alkoxymethyl alkynyl ether compounds having terminal triple bond | 信越化学工业株式会社 | 2021-06-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11661394-B2 | 6-hydroxy-3-hexenyl alkoxymethyl ether compound and a process for preparing a 3,13-octadecadien-1-ol compound from the same | CYP8B1, OXER1, CYP2E1 | TSHR 2178/4885CYP3A4 82/4885SMN1; SMN2 3662/4885 |
| US-20210198172-A1 | PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND | CBR3, CBR1, AOC2 | TSHR 2045/4885CYP3A4 380/4885SMN1; SMN2 3687/4885 |
| US-12060323-B2 | 6-hydroxy-3-hexenyl alkoxymethyl ether compound and a process for preparing a 3,13-octadecadien-1-ol compound from the same | CYP8B1, CYP2E1, OXER1 | TSHR 2266/4885CYP3A4 70/4885SMN1; SMN2 3680/4885 |
| US-11384041-B2 | Process for preparing an alkoxymethyl alkynyl ether compound having a terminal triple bond | CBR3, CBR1, AOC2 | TSHR 2045/4885CYP3A4 380/4885SMN1; SMN2 3687/4885 |
| US-20230312454-A1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | CYP8B1, CYP2E1, OXER1 | TSHR 2358/4885CYP3A4 83/4885SMN1; SMN2 3674/4885 |
| US-20220106252-A1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | CYP8B1, OXER1, CYP2E1 | TSHR 2178/4885CYP3A4 82/4885SMN1; SMN2 3662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.